| 前收市價 | 0.1500 |
| 開市 | 0.1100 |
| 買盤 | 0.0000 |
| 賣出價 | 0.0100 |
| 拍板 | 2.00 |
| 到期日 | 2024-05-17 |
| 今日波幅 | 0.0100 - 0.1200 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 30.36k |
ReutersCannabis stocks rally after DOJ proposal to reclassify marijuana
Cannabis stocks including Tilray, Curaleaf, and the AdvisorShares Pure US Cannabis ETF rallied on Thursday after the U.S. Department of Justice unveiled a historic proposal to ease restrictions on marijuana. Under the proposal, cannabis would be reclassified from a so-called Schedule I drug, which are considered highly additive with no medical benefits, to a Schedule III, signifying it has moderate to low potential for physical and psychological dependence. "No safety concerns were identified in the FDA's review that would indicate that medical use of marijuana poses unacceptably high safety risks," the proposal says.
Barrons.comPot Stocks Surge as Biden ‘Reschedules’ Marijuana
A change in classification is moving closer to reality. Multistate weed sellers would be the immediate beneficiaries.
Motley FoolWhy Aurora Cannabis, Tilray Brands, and SNDL Inc. Stocks Lit Up on Tuesday
If you think this new law will measurably increase marijuana sales, you must be smoking something.
